Literature DB >> 3162197

Potentiation of nitrosourea cytotoxicity in human leukemic cells by inactivation of O6-alkylguanine-DNA alkyltransferase.

S L Gerson1, J E Trey, K Miller.   

Abstract

The HL-60 promyelocytic leukemia cell line is resistant to nitrosoureas and contains high levels of the DNA repair protein O6-alkylguanine-DNA alkyltransferase (alkyltransferase). We examined the protective role of the alkyltransferase in the nitrosourea resistance observed in this myeloid leukemia cell line to determine whether inactivation of the alkyltransferase with the modified base, O6-methylguanine (O6mGua), could sensitize these cells to nitrosoureas. The HL-60 cells were sensitized approximately 3.0-fold to five different nitrosoureas when the alkyltransferase was inactivated by 88% following a 24-h preincubation in 0.5 mM O6mGua. No effect of O6mGua preincubation was observed in the K562 chronic myelogenous leukemia cell line which is sensitive to nitrosoureas and has low levels of alkyltransferase activity. When regeneration of HL-60 alkyltransferase activity after exposure to nitrosoureas was prevented by maintaining cells in O6mGua, HL-60 became even more sensitive (3.7- to 8.5-fold) to nitrosoureas but remained slightly more resistant than K562. Next, we compared the dose of methyl- and chloroethylnitrosoureas which were cytotoxic in HL-60 with the dose which caused repair-induced inactivation of the alkyltransferase. Both methyl- and chloroethyl-nitrosoureas caused the dose-dependent inactivation of the alkyltransferase and with both, cytotoxicity was increased with O6mGua exposure. However, chloroethylnitrosoureas, which form a variety of O6 alkylation adducts, some of which are poorly repaired, exhibited 7-12 times more cytotoxicity relative to repair-induced inactivation of the alkyltransferase whereas methylnitrosoureas became cytotoxic only when the alkyltransferase had been inactivated. These data suggest that leukemic cells are sensitized to both methyl- and chloroethylnitrosoureas when O6mGua is used to persistently inactivate the alkyltransferase. However, the alkyltransferase provides more efficient protection from methylnitrosoureas than chloroethylnitrosoureas most likely because the latter form adducts which are poorly repaired by the protein and which if unrepaired may become cytotoxic cross-links.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3162197

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  23 in total

1.  Depletion of O6-alkylguanine-DNA alkyltransferase activity in mammalian tissues and human tumor xenografts in nude mice by treatment with O6-methylguanine.

Authors:  M E Dolan; G L Larkin; H F English; A E Pegg
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

2.  Effect of temozolomide and dacarbazine on O6-alkylguanine-DNA alkyltransferase activity and sensitivity of human tumor cells and xenografts to 1,3-bis(2-chloroethyl)-1-nitrosourea.

Authors:  R B Mitchell; M E Dolan
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

3.  Lethality to leukemia cell lines of DNA interstrand cross-links generated by Cloretazine derived alkylating species.

Authors:  Philip G Penketh; Raymond P Baumann; Kimiko Ishiguro; Krishnamurthy Shyam; Helen A Seow; Alan C Sartorelli
Journal:  Leuk Res       Date:  2008-05-13       Impact factor: 3.156

4.  Treatment of subcutaneous and intracranial brain tumor xenografts with O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea.

Authors:  G M Felker; H S Friedman; M E Dolan; R C Moschel; C Schold
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

5.  Glutathione, cell proliferation, and 1,3-bis-(2-chloroethyl)-1-nitrosourea in K562 leukemia.

Authors:  H Frischer; E J Kennedy; R Chigurupati; M Sivarajan
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

6.  Sequential therapy with dacarbazine and carmustine: a phase I study.

Authors:  R B Mitchell; M E Dolan; L Janisch; N J Vogelzang; M J Ratain; R L Schilsky
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

7.  Interrelationship between O6-alkylguanine-DNA alkyltransferase activity and susceptibility to chloroethylnitrosoureas in several glioma cell lines.

Authors:  T Hotta; Y Saito; T Mikami; K Kurisu; K Kiya; T Uozumi; G Isowa; K Ishizaki; M Ikenaga
Journal:  J Neurooncol       Date:  1993-07       Impact factor: 4.130

8.  In vivo depletion of O6-alkylguanine-DNA-alkyltransferase in lymphocytes and melanoma of patients treated with CB 10-277, a new DTIC analogue.

Authors:  S M Lee; N Thatcher; D Crowther; G P Margison
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

9.  Potential of O6-methylguanine or O6-benzylguanine in the enhancement of chloroethylnitrosourea cytotoxicity on brain tumours.

Authors:  K Mineura; I Izumi; K Watanabe; M Kowada; K Kohda; M Ikenaga
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

10.  Enhancement of ACNU cytotoxicity by pretreatment with O6-methylguanine in ACNU-resistant brain tumors.

Authors:  K Mineura; I Izumi; K Watanabe; M Kowada
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.